Your browser doesn't support javascript.
loading
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Brodie, Martin J; Fakhoury, Toufic; McDonough, Belinda; Colson, Anny-Odile; Stockis, Armel; Elmoufti, Sami; Whitesides, John.
Afiliação
  • Brodie MJ; Epilepsy Unit, West Glasgow ACH-Yorkhill, Glasgow, UK. Electronic address: Martin.Brodie@glasgow.ac.uk.
  • Fakhoury T; St. Joseph Health System, Lexington, KY, USA.
  • McDonough B; UCB Pharma, Slough, UK.
  • Colson AO; UCB Pharma, Braine l'Alleud, Belgium.
  • Stockis A; UCB Pharma, Braine l'Alleud, Belgium.
  • Elmoufti S; UCB Pharma, Raleigh, NC, USA.
  • Whitesides J; UCB Pharma, Raleigh, NC, USA.
Epilepsy Res ; 145: 55-62, 2018 09.
Article em En | MEDLINE | ID: mdl-29908435

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirrolidinonas / Carbamazepina / Epilepsia / Anticonvulsivantes Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirrolidinonas / Carbamazepina / Epilepsia / Anticonvulsivantes Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article